Literature DB >> 6128282

A double-blind controlled evaluation of Actifed and its individual constituents in allergic rhinitis.

J T Connell, B O Williams, S Allen, A Cato, J G Perkins.   

Abstract

Pseudoephedrine and triprolidine, administered every 6 hours as a combination, made separate and distinct contributions to the treatment of allergic rhinitis. Furthermore, the combination was perceived by the patients as being clinically superior to either of its components or placebo.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6128282     DOI： 10.1177/030006058201000505

Source DB:  PubMed          Journal:  J Int Med Res        ISSN： 0300-0605            Impact factor:   1.671


  3 in total

1.  Development and evaluation of a novel modified-release pellet-based tablet system for the delivery of loratadine and pseudoephedrine hydrochloride as model drugs.

Authors:  Farrukh Zeeshan; Nadeem Irfan Bukhari
Journal:  AAPS PharmSciTech       Date:  2010-05-22       Impact factor: 3.246

2.  Comparison of pseudoephedrine and triprolidine, alone and in combination in preventing nasal congestion in subjects with allergic rhinitis using nasal histamine challenge.

Authors:  D W Empey; M F Frosolono; D T Hughes; J G Perkins
Journal:  Br J Clin Pharmacol       Date:  1984-07       Impact factor: 4.335

3.  Effects of terfenadine and pseudoephedrine, alone and in combination in a nasal provocation test and in perennial rhinitis.

Authors:  S Henauer; M Seppey; C Huguenot; A Pécoud
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.